| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/30/2003 | WO2002010393A3 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 01/30/2003 | WO2002004526A3 Production of a cellulose-like polysaccharide by peudomonas fluorescens |
| 01/30/2003 | WO2002004491A3 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
| 01/30/2003 | WO2002002809A3 Diagnosis of behavioural disorders, neurological disorders and cancer |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | WO2002000617A3 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/30/2003 | WO2001094946A3 Microarrays for performing proteomic analyses |
| 01/30/2003 | WO2001092877A3 Method of identifying and/or isolating stem cells |
| 01/30/2003 | WO2001092872A3 Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen |
| 01/30/2003 | WO2001090359A3 G-protein coupled receptors |
| 01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 01/30/2003 | WO2001077172A3 Non-endogenous, constitutively activated known g protein-coupled receptors |
| 01/30/2003 | WO2001068853A3 Immunogenic ovarian cancer genes |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |
| 01/30/2003 | WO2001051665A3 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/30/2003 | WO2001033228A9 Cancer diagnosis employing cell-sorting and gene-profiles |
| 01/30/2003 | US20030024008 Amplification of crop yield; obtain nucleotide sequences, generate vector, infect cells, recover transform cells, propagate and monitor seed generation |
| 01/30/2003 | US20030024001 Animal models for use in the treatment of psychological and nervous system disorders |
| 01/30/2003 | US20030024000 Animal models for use in the treatment of injuries and psoriasis |
| 01/30/2003 | US20030023997 Transgenic c. elegans as a model organism for investigations on alzheimer's disease |
| 01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
| 01/30/2003 | US20030023990 Jnk3 modulators and methods of use |
| 01/30/2003 | US20030023403 Process for estimating random error in chemical and biological assays when random error differs across assays |
| 01/30/2003 | US20030023387 Computer-assisted means for assessing lifestyle risk factors |
| 01/30/2003 | US20030023385 Statistical analysis method for classifying objects |
| 01/30/2003 | US20030023317 Membrane for use with implantable devices |
| 01/30/2003 | US20030023089 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
| 01/30/2003 | US20030023077 Used to extract DNA from dried biological samples on solid substrates, including but not limited to, buccal smears, semen and especially blood |
| 01/30/2003 | US20030023076 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration |
| 01/30/2003 | US20030023070 For diagnosis, prophylaxis and therapy; therapy of cancer |
| 01/30/2003 | US20030023064 Novel human phosphatases and polynucleotides encoding the same |
| 01/30/2003 | US20030023059 SR-BI nucleic acids and uses therefor |
| 01/30/2003 | US20030023057 Used in assaying for cancer, such as melanoma |
| 01/30/2003 | US20030023056 In immunogenic preparations or diagnostic applications |
| 01/30/2003 | US20030023054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030023036 Drugs, vaccines |
| 01/30/2003 | US20030023034 p27 (Kip1) -FKBP-12 protein complexes |
| 01/30/2003 | US20030023033 Novel class II cytokine receptors and uses thereof |
| 01/30/2003 | US20030022866 Analgesic inhibitor of isoforms of cyclic guanosine monophosphate (cGMP)-dependent protein kinase I alpha (PKGI alpha); drug screening |
| 01/30/2003 | US20030022858 Genes involved in the DNA regulation cascade (cell cycle disorders, DNA repair, tumorigenesis/tumor progression) which are associated with pathophysiology phenotype of Fanconi anaemia |
| 01/30/2003 | US20030022855 Melanoma differentiation associated gene-5 (mda-5) nucleic acids, proteins, and gene promoters for induction of apoptotic cell death |
| 01/30/2003 | US20030022853 Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
| 01/30/2003 | US20030022849 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/30/2003 | US20030022822 Novel compounds |
| 01/30/2003 | US20030022393 Apparatus for in generation surface-mounted optics and material surfaces |
| 01/30/2003 | US20030022367 Cells for use as models in the treatment of heart defects |
| 01/30/2003 | US20030022358 Membrane for use in the propagation and detection of preferential microorganisms |
| 01/30/2003 | US20030022349 Virulence-associated nucleic acid sequences and uses thereof |
| 01/30/2003 | US20030022340 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 01/30/2003 | US20030022339 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | US20030022338 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 01/30/2003 | US20030022331 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022325 Nucleotide sequences coding transport protein for use in diagnosis and treatment of cancers, kidney, bone and nervous sysem disorders |
| 01/30/2003 | US20030022318 Method for thermocycling amplification of nucleic acid sequences and the generation of related peptides thereof |
| 01/30/2003 | US20030022312 Human hepatoma-derived growth factor-2 |
| 01/30/2003 | US20030022290 Method for modulating processes mediated by farnesoid activated receptors |
| 01/30/2003 | US20030022288 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 01/30/2003 | US20030022277 Nucleotide sequences coding polypeptide or use in the treatment of eating disorders |
| 01/30/2003 | US20030022275 Human nk-3 related prostate specific gene-1 |
| 01/30/2003 | US20030022269 Monitoring chemotaxis of cells; obtain cells, insert into container, expose to substrate, monitor migration of cells |
| 01/30/2003 | US20030022268 Method and apparatus for patch-clamp measurements on cells |
| 01/30/2003 | US20030022266 Novel agents for replacement of NAD+/NADH system in enzymatic reactions |
| 01/30/2003 | US20030022265 Plasmid coding preferential enzymatic polypetide for use in the evaluation enzyme substrates |
| 01/30/2003 | US20030022264 Sodium activation of amylase |
| 01/30/2003 | US20030022263 ATM kinase modulation for screening and therapies |
| 01/30/2003 | US20030022251 Gamma-secretase in vitro screening assay |
| 01/30/2003 | US20030022247 Inhibition of signal transduction for use as tool in treatment of cell proliferation disorders; obtain sample containing enzymatic polypeptide, incubate with modulator, monitor adjustment in phosphorylation activity |
| 01/30/2003 | US20030022241 Detection of modulators of enzyme activity; obtain sample containing kinase activity, incubate with modulator, monitor diabetic response |
| 01/30/2003 | US20030022238 Methods of identifying agents which inhibit GPR-9-6 |
| 01/30/2003 | US20030022237 Novel human G-protein coupled receptor, HGPRBMY4, expressed highly in prostate, colon, and lung |
| 01/30/2003 | US20030022236 Generation of preferental protein libraries; obtain nucleotide sequences, translate in vitro, recover protein product |
| 01/30/2003 | US20030022232 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 01/30/2003 | US20030022231 Detection of nucleic acids |
| 01/30/2003 | US20030022227 Hybridization substrate for use in genome analysis and bacterial detection |
| 01/30/2003 | US20030022225 Releasable nonvolatile mass-label molecules |
| 01/30/2003 | US20030022222 HADHs as modifiers of the p21 pathway and methods of use |
| 01/30/2003 | US20030022220 Methods and compositions for modulating adenosine triphosphate (ATP) in cells and preventing cell injury or death via post-translational modifications to ATP synthase |
| 01/30/2003 | US20030022215 Detection of nucleotide sequence mutation in gene; obtain target nucleotide sequences, incubate with control nucleotide sequences, remove phosphate groups, ligate linker, amplify nucleotide sequences, compare to control, detect mutation |
| 01/30/2003 | US20030022214 Nucleotide sequences coding polypeptide for use in the detection of bacterial impurities in food processing and foods |
| 01/30/2003 | US20030022211 Nucleotide sequences coding polypeptide for use in diagnosis and prevention of psychological and nervous system disorders |
| 01/30/2003 | US20030022209 ADSLs as modifiers of the p53 pathway and methods of use |
| 01/30/2003 | US20030022207 Arrayed polynucleotides and their use in genome analysis |
| 01/30/2003 | US20030022206 Method of characterizing a homeopathic preparation |
| 01/30/2003 | US20030022204 Method for detecting multiple copies of a repeat sequence in a nucleic acid molecule |
| 01/30/2003 | US20030022200 Systems for analysis of biological materials |
| 01/30/2003 | US20030022199 Transporter genes OATP-B,C,D, and E |
| 01/30/2003 | US20030022198 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 01/30/2003 | US20030022197 Device for monitoring haptotaxis |
| 01/30/2003 | US20030022196 Methods and compositions for screening for altered cellular phenotypes |
| 01/30/2003 | US20030022194 Amplification of preferential nucleotide sequences; obtain nucleotide sequences, denature, incubate with primer, transcribe, recover and amplify nucleotide sequences |
| 01/30/2003 | US20030022193 Method for purification and subsequent determination of double-strand DNA |
| 01/30/2003 | US20030022192 Geenration of nucleotide sequences library; obtain nucleotide sequences, incubate with vector, digest, ligate, recover and vector with nucleotide sequence insertion, transform cells with vector, propagate cells, recover library |
| 01/30/2003 | US20030022191 Diagnosing mammary gland cancer in humans, obtain tissue sample, extract nucleotide sequence, amplify, electrophorese, incubate with probe, monitor pattern, detect polymorphisms |
| 01/30/2003 | US20030022190 Detection of mutaion in tissue sample; obtain tissue, extract nucleotide sequences, incubate with probe, detect signal, presence oof signal indicates cancer |
| 01/30/2003 | US20030022188 Compositions and methods relating to colon specific genes and proteins |
| 01/30/2003 | US20030022187 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022186 Novel human G-protein coupled receptor, hgprbmy18, expressed highly in pituitary gland and colon carcinoma cells |
| 01/30/2003 | US20030022184 Protein for use in the diagnosis, prevention and treatment of mammary gland cancer |
| 01/30/2003 | US20030022182 Detection of preferential nucleotide sequences on solid support; generate solid support, incubate with nucleotide sequences, expose to probe, detect signal, presence of signal indicates preferential nucleotide sequences |